ANI Pharmaceuticals, Inc., a specialty pharmaceutical and contract development and manufacturing organization (CDMO), has launched its new CDMO brand, ANI Global Source. This follows the integration of WellSpring Pharma Services, acquired last year, and the company’s progress since the acquisition. 

ANI Global Source is a specialty CDMO supporting late stage development and commercial manufacture of pharmaceutical products including tablets and capsules, liquid solutions, suspensions, topical liquids, creams and gels, with unique expertise in hormones, potent compounds, and controlled substances. ANI Global Source will continue to leverage its robust infrastructure of 300 employees and 270,000 sq.-ft. of manufacturing and packaging facilities across multiple sites.

Visit ANI at CPhI Worldwide booth 121H63.